home / stock / brsyf / brsyf news

BRSYF News and Press, Brainsway Ltd Ord

Stock Information
Company Name: Brainsway Ltd Ord
Stock Symbol: BRSYF
Market: OTC
Website: brainsway.com
Menu
BRSYF BRSYF Quote BRSYF Short BRSYF News BRSYF Articles BRSYF Message Board
Get BRSYF Alerts

News, Short Squeeze, Breakout and More Instantly...
BRSYF - BrainsWay Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Q4 Revenue Grew 27% Year-Over-Year to Record $14.5 Million Q4 Operating Income of $1.9 Million; Adjusted EBITDA Increased by 53% to $2.3 Million, Reflecting Significant Operating Leverage  Full Year 2025 Revenue Increased by Approximately 27% YoY to $52.2 Million, and Net Income Incr...
BRSYF - Landmark Data Validate BrainsWay's SWIFT(TM) Deep TMS, Beginning a New Era in Depression Treatment

BURLINGTON, Mass. and JERUSALEM, March 04, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) unveiled new clinical data showing a significantly faster, noninvasive way to treat depression without compromising the efficacy of one of psychiatry’s most impactful treatments...

BRSYF - BrainsWay to Report Fourth Quarter and Full Year 2025 Financial Results on March 11, 2026

BURLINGTON, Mass. and JERUSALEM, Feb. 25, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation technologies, today announced that it will report its fourth quarter and...

BRSYF - BrainsWay to Participate in the Citi 2026 Unplugged MedTech and Life Sciences Access Day

BURLINGTON, Mass. and JERUSALEM, Feb. 23, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced that management will participate in one-o...
BRSYF - BrainsWay Announces New Minority-Stake Investment in Canadian Provider, BrainStim Health Inc.

BrainsWay continues to activel y evaluat e similar investments in l eading North American m ental h ealth p roviders to raise awareness and e xpand a ccess to transformative care BURLINGTON, Mass. and JERUSALEM, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Brains...

BRSYF - BrainsWay Reports Cigna's Evernorth Behavioral Health to Eliminate Prior Authorization Requirements for TMS Coverage, Accelerating Access to Care

BURLINGTON, Mass. and JERUSALEM, Feb. 18, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today commented on the recent  news issued by Evern...

BRSYF - BrainsWay to change in ADS ratio to 1-for-1, effective March 3

2026-02-17 07:54:45 ET More on BrainsWay BrainsWay Ltd. (BWAY) Analyst/Investor Day Transcript BrainsWay Ltd. (BWAY) Analyst/Investor Day - Slideshow Seeking Alpha’s Quant Rating on BrainsWay Historical earnings data for BrainsWay Financial inf...
BRSYF - BrainsWay Announces Change in ADS-to-Ordinary Share Ratio

BURLINGTON, Mass. and JERUSALEM, Feb. 17, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced that its Board of Directors approved a pl...

BRSYF - BrainsWay Announces Draft Coverage Policy from Highmark® for Accelerated Deep TMS(TM)

BURLINGTON, Mass. and JERUSALEM, Jan. 21, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced that Highmark Blue Cross Blue Shield ...

BRSYF - BrainsWay Announces FDA Approval of Neurolief's Proliv(TM)Rx Neuromodulation System for Major Depressive Disorder (MDD)

BURLINGTON, Mass. and JERUSALEM, Jan. 12, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced that the U.S. Food and Drug Administratio...
Next 10